SML0702
MRT67307 盐酸盐
≥98% (HPLC), IKKe and TBK-1 inhibitor, powder
别名:
N-[3-[[5-环丙基-2-[[3-（4-吗啉基甲基）苯基] 氨基]-4-嘧啶基] 氨基] 丙基]-环丁基甲酰胺 盐酸盐
产品名称
MRT67307 盐酸盐, ≥98% (HPLC)
质量水平
方案
≥98% (HPLC)
表单
powder
储存条件
desiccated
颜色
white to light brown
溶解性
H2O: 15 mg/mL, clear
储存温度
2-8°C
SMILES字符串
N5(CCOCC5)Cc1cc(ccc1)Nc2nc(c(cn2)C4CC4)NCCCNC(=O)C3CCC3
InChI
1S/C26H36N6O2/c33-25(21-5-2-6-21)28-11-3-10-27-24-23(20-8-9-20)17-29-26(31-24)30-22-7-1-4-19(16-22)18-32-12-14-34-15-13-32/h1,4,7,16-17,20-21H,2-3,5-6,8-15,18H2,(H,28,33)(H2,27,29,30,31)
InChI key
UKBGBACORPRCGG-UHFFFAOYSA-N
应用
MRT67307 盐酸盐已用于研究其对 LPS（脂多糖）诱导溶酶体管状结构的影响。
生化/生理作用
MRT67307 是 IKKe 和 TBK-1 的双重抑制剂。
MRT67307 是 IKKe 和 TBK-1 的双重抑制剂。IKKe 和 TBK-1 介导干扰素调节因子 3 (IRF3) 的磷酸化。
MRT67307 是氨基嘧啶衍生物，IC 50 值为 19。已知其可诱导 TLR（toll 样受体）介导的抗炎细胞因子生成。此外，MRT67307 还可预防促炎相关细胞因子的分泌。
储存分类代码
11 - Combustible Solids
WGK
WGK 3
闪点(°F)
Not applicable
闪点(°C)
Not applicable
历史批次信息供参考:
分析证书(COA)
Lot/Batch Number
Zachary P Guinn et al.
Immunobiology, 224(4), 565-574 (2019-05-11)
IFN-γ produced during viral infections activates the IFN-γ receptor (IFNGR) complex for STAT1 transcriptional activity leading to expression of Interferon Regulatory Factors (IRF). Simultaneous activation of TBK/IKKε via TLR3 during viral infections activates the transcription factor IRF3. Together these transcription factors
Daniel P.
The Inhibitor Index: A Desk Reference on Enzyme Inhibitors, Receptor Antagonists, Drugs, Toxins, Poisons, Biologics, and Therapeutic Leads (2017)
Therapeutic potential of targeting TBK1 in autoimmune diseases and interferonopathies.
Hasan M and Nan Y
Pharmacological Research, 111, 336-342 (2016)
mTOR controls lysosome tubulation and antigen presentation in macrophages and dendritic cells.
Saric A, et al.
Molecular Biology of the Cell, 27(2), 321-333 (2016)
Nadia Carvalho Lima et al.
International journal of molecular sciences, 21(9) (2020-05-07)
Selective FGFR inhibitors such as infigratinib (BGJ398) and erdafitinib (JNJ-42756493) have been evaluated in clinical trials for cancers with FGFR3 molecular alterations, particularly in urothelial carcinoma patients. However, a substantial proportion of these patients (up to 50%) display intrinsic resistance
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持